Ribas Seguí, D.
Forcadell, MJosé
Vila-Córcoles, Angel
de Diego-Cabanes, Cinta
Ochoa-Gondar, Olga
Lujan, Francisco Martin
Gracia, Eva Satué
Article History
Received: 24 December 2024
Accepted: 9 April 2025
First Online: 25 April 2025
Declarations
:
: All the authors: D Ribas Seguí, M José Forcadell, Angel Vila-Córcoles, Cinta de Diego, Olga Ochoa-Gondar, Francisco Martin Lujan and Eva Satué consent to participate in the manuscript.
: This study was conducted in accordance with the principles of the Declaration of Helsinki and the guidelines of good clinical practice. Due to the retrospective nature of the study, the Ethics Committee for Clinical Research (CEIC) of the Instituto de Investigación en Atención Primaria (IDIAP) Jordi Gol waived the need to obtain informed consent. This study was conducted within the framework of the CAPAMIS project, (Evaluation of the effectiveness of the pneumococcal 23-valent vaccine to prevent pneumonia and acute vascular events in the population over 60 years) project,which was reviewed and approved by the IDIAP Jordi Gol ethics committee in 2009 (file 4R09/019). The protocol of the project was published in BMC Public Health Journal (https://doi.org/10.1186/1471 - 2458 - 10 - 25). Also received a grant from the"Instituto de Salud Carlos III"(file PI09/0043) whose budget has already been exhausted. The project included a follow-up of the cohort with the update of monitoring variables and study events. This information was provided to the research team in pseudonym by a member of the institutional Information and Communication Technology Unit.
: The authors declare no competing interests.